Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: First comparative study

American Journal of Clinical Pathology

Volumn 142, Issue 1, 2014, Pages 104-110

  Razmpoosh, Maryam ^a   Sansregret, Andrée ^a   Oligny, Luc L ^a   Patey, Natalie ^a   Dormoy Raclet, Virginie ^a   Ducruet, Thierry ^a   Bouron Dal Soglio, Dorothée ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cervical intraepithelial neoplasia grade 1; CIN1; HPV subtype; Human papillomavirus; Low grade squamous intraepithelial lesion; LSIL; p16; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY TEST KIT; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PILOT STUDY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 1; CIN1; COMPARATIVE STUDY; DISEASE COURSE; HPV SUBTYPE; ISOLATION AND PURIFICATION; LOW-GRADE SQUAMOUS INTRAEPITHELIAL LESION; LSIL; METABOLISM; MIDDLE AGED; P16; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VIROLOGY;

CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 1; CIN1; HPV SUBTYPE; HUMAN PAPILLOMAVIRUS; LOW-GRADE SQUAMOUS INTRAEPITHELIAL LESION; LSIL; P16; PROGNOSIS;

ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84904558817     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPBX74QXCPXIKK     Document Type: Article

References (20)

1. World Health Organization (WHO). Human Papillomavirus and Related Cancers: Summary Report Update. Geneva, Switzerland: WHO; 2010.
2. el Hamidi A, Kocjan G, Du MQ. Clonality analysis of archival cervical smears: correlation of monoclonality with grade and clinical behavior of cervical intraepithelial neoplasia. Acta Cytol. 2003;47:117-123. (Pubitemid 36367916)
3. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423-428. (Pubitemid 28135669)
4. Schlecht NF, Platt RW, Duarte-Franco E, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst. 2003;95:1336-1343. (Pubitemid 37160867)
5. Schneider V. CIN prognostication: will molecular techniques do the trick? Acta Cytol. 2003;47:115-116. (Pubitemid 36367915)
6. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907. (Pubitemid 47371147)
7. Cox JT, Schiffman M, Solomon D. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003;188:1406-1412. (Pubitemid 36741266)
8. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186-192. (Pubitemid 23095196)
9. Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003;189:295-304. (Pubitemid 36886564)
10. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007;197:340-345. (Pubitemid 47464166)
11. Schiffman M, Khan MJ, Solomon D, et al. A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst. 2005;97:147-150. (Pubitemid 40277095)
12. Massad LS, Einstein MH, Huh WK, et al. 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17(suppl 1):S1-S27.
13. del Pino M, Garcia S, Fusté V, et al. Value of p161NK4a as a marker of progression/regression in cervical intraepithelial neoplasia grade 1. Am J Obstet Gynecol. 2009;201:488.e1-7.
14. Hariri J, Oster A. The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int J Gynecol Pathol. 2007;26:223-228. (Pubitemid 46986053)
15. Negri G, Vittadello F, Romano F, et al. p161NK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch. 2004;445:616-620. (Pubitemid 40104537)
16. Darragh TM, Colgan TJ, Cox JT, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med. 2012;136:1266-1297.
17. Galgano MT, Castle PE, Atkins KA, et al. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010;34:1077-1087.
18. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389-1399. (Pubitemid 35239415)
19. Dray M, Russell P, Dalrymple C, et al. p16INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix, I: experience with squamous lesions in 189 consecutive cervical biopsies. Pathology. 2005;37:112-124. (Pubitemid 40593402)
20. Feoli-Fonseca JC, Oligny LL, Brochu P, et al. Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol. 2001;63:284-292. (Pubitemid 32195392)